Microsoft launches MAI-DxO: an AI that outperforms doctors in complex diagnostics

What is MAI-DxO?

Microsoft has developed a diagnostic orchestrator that coordinates several language models to replicate the clinical process: analyzing symptoms, formulating questions, requesting tests, and reaching a conclusion. According to The Verge, the system is powered by GPT-5 from OpenAI. The system is tested in a simulated environment called Sequential Diagnostic Reference Point, based on 304 real cases from the New England Journal of Medicine.

Key results

The orchestrator, when combined with OpenAI's o3 model, resolves between 80% and 85.5% of simulated clinical cases.

Why is it important?

• Clinical efficiency: AI strategically selects tests, reducing costs without sacrificing accuracy.
• Scalability: Microsoft plans to integrate MAI-DxO into Copilot and Bing Health, platforms with more than 50 million daily sessions related to health.
• Medical superintelligence: Microsoft AI CEO Mustafa Suleyman describes the tool as a step towards "medical superintelligence" that would operate with "practically no errors" in the next five to ten years.

Limitations and regulatory challenges

1. Simulated tests vs. real practice: The study was conducted with historical cases and doctors without access to literature or colleagues, which does not reflect usual clinical practice.
2. Pending clinical validation: Microsoft acknowledges that it needs comparative clinical trials in real environments before obtaining regulatory approval.
3. Responsibility and ethics: Although AI can reduce the diagnostic burden, the doctor's role in final decision-making, uncertainty management, and trust generation remains essential.

Future perspectives

• Microsoft plans to start tests in real hospitals (Beth Israel Deaconess) to evaluate performance under authentic clinical conditions.
• Commercial deployment will depend on regulatory approval and a responsible strategy that meets the high compliance requirements of the healthcare sector.

Conclusion: MAI-DxO demonstrates a significant advance in AI-assisted diagnosis, outperforming human doctors in accuracy within a controlled environment. However, its clinical adoption will require real validation, regulatory supervision, and a clear definition of responsibilities between technology and healthcare professionals.